Literature DB >> 25455073

A network approach to clinical intervention in neurodegenerative diseases.

Jose A Santiago1, Judith A Potashkin2.   

Abstract

Network biology has become a powerful tool to dissect the molecular mechanisms triggering neurodegeneration. Recent developments in network biology have led to the discovery of disease-causing genes, diagnostic biomarkers, and therapeutic targets for several neurodegenerative diseases including Alzheimer's, Parkinson's, and Huntington's diseases. Network-based approaches have provided the molecular rationale for the relationship among cancer, diabetes, and neurodegenerative diseases, and have uncovered unexpected links between apparently unrelated diseases. Here, we summarize the recent advances in network biology to untangle the molecular underpinnings giving rise to the most prevalent neurodegenerative diseases. We propose that network analysis provides a feasible and practical tool for identifying biologically meaningful biomarkers and potential therapeutic targets for clinical intervention in neurodegenerative diseases.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; Parkinson's disease; network biology; neurodegenerative diseases

Mesh:

Year:  2014        PMID: 25455073     DOI: 10.1016/j.molmed.2014.10.002

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN: 1471-4914            Impact factor:   11.951


  27 in total

1.  Network-based metaanalysis identifies HNF4A and PTBP1 as longitudinally dynamic biomarkers for Parkinson's disease.

Authors:  Jose A Santiago; Judith A Potashkin
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-02       Impact factor: 11.205

2.  Reply to Toker and Pavlidis: Blood biomarkers for Parkinson's disease.

Authors:  Jose A Santiago; Judith A Potashkin
Journal:  Proc Natl Acad Sci U S A       Date:  2015-06-23       Impact factor: 11.205

3.  Network Analysis Identifies Sex-Specific Gene Expression Changes in Blood of Amyotrophic Lateral Sclerosis Patients.

Authors:  Jose A Santiago; James P Quinn; Judith A Potashkin
Journal:  Int J Mol Sci       Date:  2021-07-01       Impact factor: 5.923

4.  Metabolic network failures in Alzheimer's disease: A biochemical road map.

Authors:  Jon B Toledo; Matthias Arnold; Gabi Kastenmüller; Rui Chang; Rebecca A Baillie; Xianlin Han; Madhav Thambisetty; Jessica D Tenenbaum; Karsten Suhre; J Will Thompson; Lisa St John-Williams; Siamak MahmoudianDehkordi; Daniel M Rotroff; John R Jack; Alison Motsinger-Reif; Shannon L Risacher; Colette Blach; Joseph E Lucas; Tyler Massaro; Gregory Louie; Hongjie Zhu; Guido Dallmann; Kristaps Klavins; Therese Koal; Sungeun Kim; Kwangsik Nho; Li Shen; Ramon Casanova; Sudhir Varma; Cristina Legido-Quigley; M Arthur Moseley; Kuixi Zhu; Marc Y R Henrion; Sven J van der Lee; Amy C Harms; Ayse Demirkan; Thomas Hankemeier; Cornelia M van Duijn; John Q Trojanowski; Leslie M Shaw; Andrew J Saykin; Michael W Weiner; P Murali Doraiswamy; Rima Kaddurah-Daouk
Journal:  Alzheimers Dement       Date:  2017-03-22       Impact factor: 16.655

Review 5.  Current and future implications of basic and translational research on amyloid-β peptide production and removal pathways.

Authors:  C Bohm; F Chen; J Sevalle; S Qamar; R Dodd; Y Li; G Schmitt-Ulms; P E Fraser; P H St George-Hyslop
Journal:  Mol Cell Neurosci       Date:  2015-03-04       Impact factor: 4.314

Review 6.  Current Challenges Towards the Development of a Blood Test for Parkinson's Disease.

Authors:  Jose A Santiago; Judith A Potashkin
Journal:  Diagnostics (Basel)       Date:  2014-10-22

Review 7.  Biological and Clinical Implications of Comorbidities in Parkinson's Disease.

Authors:  Jose A Santiago; Virginie Bottero; Judith A Potashkin
Journal:  Front Aging Neurosci       Date:  2017-12-04       Impact factor: 5.750

8.  Exploring the cross talk between ER stress and inflammation in age-related macular degeneration.

Authors:  Samira Kheitan; Zarrin Minuchehr; Zahra-Soheila Soheili
Journal:  PLoS One       Date:  2017-07-24       Impact factor: 3.240

9.  Proteomic Profiling of Cranial (Superior) Cervical Ganglia Reveals Beta-Amyloid and Ubiquitin Proteasome System Perturbations in an Equine Multiple System Neuropathy.

Authors:  Bruce C McGorum; R Scott Pirie; Samantha L Eaton; John A Keen; Elizabeth M Cumyn; Danielle M Arnott; Wenzhang Chen; Douglas J Lamont; Laura C Graham; Maica Llavero Hurtado; Alan Pemberton; Thomas M Wishart
Journal:  Mol Cell Proteomics       Date:  2015-09-13       Impact factor: 5.911

10.  Blood Biomarkers Associated with Cognitive Decline in Early Stage and Drug-Naive Parkinson's Disease Patients.

Authors:  Jose A Santiago; Judith A Potashkin
Journal:  PLoS One       Date:  2015-11-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.